Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

NATR

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. serves as 10% Owner at Nature's Sunshine Products, Inc. (NATR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$175.1K

Net Position

Net Seller

$175.1K

Companies Traded

NATR

Active Period

Oct 2024

2 total trades

Most Recent

Sell NATR

Oct 17, 2024 · $29.9K

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s Insider Trading at Nature's Sunshine Products, Inc. (NATR)

Buys

0 · $0.00

Sells

2 · $175.1K

Total Shares Bought

Total Shares Sold

13,195

NATR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 17, 2024	Sell	2,300	$13.02	$29.9K	64,167
Oct 15, 2024	Sell	10,895	$13.33	$145.2K	75,963

Related Insiders

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

10 percent owner

NATRBuy · Aug 19, 2026

Nathan G Brower

EVP, General Counsel

NATRSell · Nov 14, 2025

Daniel C Norman

EVP & President, Asia

NATRSell · Nov 12, 2025

Bryant J Yates

EVP & President, Europe

NATRSell · Nov 4, 2025

Explore More Insider Trading Data

NATR Insider Trading Activity

View all insider trades at Nature's Sunshine Products, Inc.

Consumer Defensive Sector Insider Trades

See insider activity across consumer defensive stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity